ResMed Operating Margin 2010-2025 | RMD

Current and historical operating margin for ResMed (RMD) over the last 10 years. The current operating profit margin for ResMed as of March 31, 2025 is 26.66%.
ResMed Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2025-03-31 $5.02B $1.61B 32.08%
2024-12-31 $4.93B $1.56B 31.66%
2024-09-30 $4.81B $1.42B 29.49%
2024-06-30 $4.69B $1.32B 28.18%
2024-03-31 $4.58B $1.21B 26.48%
2023-12-31 $4.50B $1.14B 25.31%
2023-09-30 $4.38B $1.15B 26.17%
2023-06-30 $4.22B $1.13B 26.81%
2023-03-31 $4.02B $1.11B 27.69%
2022-12-31 $3.76B $1.05B 27.76%
2022-09-30 $3.63B $1.01B 27.97%
2022-06-30 $3.58B $1.00B 27.94%
2022-03-31 $3.54B $0.99B 27.88%
2021-12-31 $3.44B $0.98B 28.34%
2021-09-30 $3.35B $0.95B 28.34%
2021-06-30 $3.20B $0.90B 28.28%
2021-03-31 $3.09B $0.89B 28.63%
2020-12-31 $3.09B $0.88B 28.47%
2020-09-30 $3.03B $0.86B 28.28%
2020-06-30 $2.96B $0.81B 27.40%
2020-03-31 $2.89B $0.71B 24.49%
2019-12-31 $2.78B $0.65B 23.24%
2019-09-30 $2.70B $0.61B 22.45%
2019-06-30 $2.61B $0.58B 22.22%
2019-03-31 $2.53B $0.61B 23.96%
2018-12-31 $2.46B $0.58B 23.79%
2018-09-30 $2.41B $0.57B 23.83%
2018-06-30 $2.34B $0.54B 23.15%
2018-03-31 $2.27B $0.52B 22.96%
2017-12-31 $2.20B $0.49B 22.45%
2017-09-30 $2.13B $0.44B 20.89%
2017-06-30 $2.07B $0.43B 20.57%
2017-03-31 $2.03B $0.42B 20.56%
2016-12-31 $1.97B $0.41B 21.04%
2016-09-30 $1.89B $0.43B 22.45%
2016-06-30 $1.84B $0.43B 23.32%
2016-03-31 $1.77B $0.41B 23.11%
2015-12-31 $1.74B $0.41B 23.65%
2015-09-30 $1.71B $0.41B 24.15%
2015-06-30 $1.68B $0.41B 24.43%
2015-03-31 $1.64B $0.41B 24.88%
2014-12-31 $1.62B $0.41B 25.19%
2014-09-30 $1.58B $0.40B 25.55%
2014-06-30 $1.56B $0.41B 26.05%
2014-03-31 $1.56B $0.39B 25.27%
2013-12-31 $1.54B $0.38B 24.92%
2013-09-30 $1.53B $0.37B 24.19%
2013-06-30 $1.52B $0.35B 23.35%
2013-03-31 $1.47B $0.36B 24.30%
2012-12-31 $1.44B $0.34B 23.57%
2012-09-30 $1.39B $0.31B 22.53%
2012-06-30 $1.37B $0.30B 21.55%
2012-03-31 $1.34B $0.27B 20.31%
2011-12-31 $1.30B $0.26B 19.88%
2011-09-30 $1.28B $0.26B 20.53%
2011-06-30 $1.24B $0.27B 21.48%
2011-03-31 $1.19B $0.27B 22.55%
2010-12-31 $1.16B $0.27B 22.95%
2010-09-30 $1.13B $0.25B 22.52%
2010-06-30 $1.09B $0.24B 22.05%
2010-03-31 $1.05B $0.23B 21.84%
2009-12-31 $1.00B $0.22B 22.16%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $37.534B $4.685B
ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $231.781B 27.87
Boston Scientific (BSX) United States $152.324B 38.13
Stryker (SYK) United States $149.641B 31.29
EssilorLuxottica (ESLOY) France $137.721B 0.00
Medtronic (MDT) Ireland $114.146B 16.18
Lonza Group Ag (LZAGY) Switzerland $51.237B 0.00
Haleon (HLN) United Kingdom $45.147B 25.77
GE HealthCare Technologies (GEHC) United States $34.575B 16.42
Agilent Technologies (A) United States $34.457B 22.46
Terumo (TRUMY) Japan $25.051B 32.54
Koninklijke Philips (PHG) Netherlands $23.235B 16.30
Insulet (PODD) United States $20.934B 82.17
Zimmer Biomet Holdings (ZBH) United States $18.835B 12.10
Baxter (BAX) United States $15.298B 11.42
Smith & Nephew SNATS (SNN) United Kingdom $13.441B 0.00
Demant (WILYY) Denmark $8.971B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.887B 23.97
Lantheus Holdings (LNTH) United States $5.776B 14.57
Prestige Consumer Healthcare (PBH) United States $3.897B 17.41
Perrigo (PRGO) Ireland $3.742B 9.48
Haemonetics (HAE) United States $3.724B 16.96
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.454B 28.70
ICU Medical (ICUI) United States $3.341B 24.63
QuidelOrtho (QDEL) United States $2.135B 14.68
LeMaitre Vascular (LMAT) United States $1.910B 42.70
AtriCure (ATRC) United States $1.580B 0.00
Acuren (TIC) United States $1.397B 0.00
Phibro Animal Health (PAHC) United States $1.272B 16.26
Green Thumb Industries (GTBIF) United States $1.249B 28.09
AdaptHealth (AHCO) United States $1.247B 12.66
Neogen (NEOG) United States $1.194B 15.28
BioLife Solutions (BLFS) United States $1.068B 0.00
InMode (INMD) Israel $0.963B 9.70
Kestra Medical Technologies (KMTS) United States $0.791B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.703B 0.00
Tilray Brands (TLRY) Canada $0.679B 0.00
Curaleaf Holdings (CURLF) Canada $0.670B 0.00
Owens & Minor (OMI) United States $0.667B 5.53
Evolus (EOLS) United States $0.623B 0.00
CeriBell (CBLL) United States $0.596B 0.00
Capricor Therapeutics (CAPR) United States $0.522B 0.00
Valneva SE (VALN) France $0.502B 0.00
Surmodics (SRDX) United States $0.441B 0.00
SNDL (SNDL) Canada $0.373B 0.00
VAREX IMAGING (VREX) United States $0.347B 12.77
Sanuwave Health (SNWV) United States $0.308B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.304B 0.00
Quanterix (QTRX) United States $0.295B 0.00
Cresco Labs (CRLBF) United States $0.291B 0.00
Cerus (CERS) United States $0.285B 0.00
Viemed Healthcare (VMD) United States $0.276B 23.27
Sanara MedTech (SMTI) United States $0.269B 0.00
ZimVie (ZIMV) United States $0.264B 12.01
Aurora Cannabis (ACB) Canada $0.257B 76.17
Brainsway (BWAY) Israel $0.246B 65.00
Canopy Growth (CGC) Canada $0.232B 0.00
OraSure Technologies (OSUR) United States $0.227B 0.00
Biote (BTMD) United States $0.225B 6.34
Verano Holdings (VRNOF) United States $0.210B 0.00
Omeros (OMER) United States $0.198B 0.00
Organigram Global (OGI) Canada $0.193B 0.00
High Tide (HITI) Canada $0.190B 0.00
TriSalus Life Sciences (TLSI) United States $0.190B 0.00
Utah Medical Products (UTMD) United States $0.186B 15.15
Vireo Growth (VREOF) United States $0.150B 0.00
Exagen (XGN) United States $0.145B 0.00
FitLife Brands (FTLF) United States $0.126B 15.53
TerrAscend (TSNDF) Canada $0.104B 0.00
MacroGenics (MGNX) United States $0.100B 0.00
Fonar (FONR) United States $0.096B 12.37
Jin Medical (ZJYL) China $0.093B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.089B 0.00
Apyx Medical (APYX) United States $0.086B 0.00
Quipt Home Medical (QIPT) United States $0.082B 0.00
Veru (VERU) United States $0.081B 0.00
Jushi Holdings (JUSHF) United States $0.072B 0.00
Zynex (ZYXI) United States $0.072B 0.00
InterCure (INCR) Israel $0.072B 0.00
Agape ATP (ATPC) $0.071B 0.00
Cytosorbents (CTSO) United States $0.070B 0.00
ImmuCell (ICCC) United States $0.061B 0.00
Rockwell Medical (RMTI) United States $0.041B 0.00
Nephros (NEPH) United States $0.040B 53.29
Modular Medical (MODD) United States $0.039B 0.00
United-Guardian (UG) United States $0.037B 12.82
Safety Shot (SHOT) United States $0.033B 0.00
Allurion Technologies (ALUR) United States $0.021B 0.00
INLIF (INLF) $0.016B 0.00
IM Cannabis (IMCC) Canada $0.014B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
Senestech (SNES) United States $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00